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Prescribing for the Ageing Patient 
Abstract 
In this article in the series of ‘bite sized’ pharmacology, we will look at the pharmacological 
considerations when prescribing for the ageing patient. This article will illustrate the common 
issues to consider when prescribing for the over 65 population. Focus will be on 
pharmacokinetics and the four processes that occur after oral drug administration, with 
specific details on the factors that affect these processes in this patient group. There will also 
be some consideration of multiple morbidity and polypharmacy and a brief area on 
compliance. Exercises provided will help you apply this knowledge to your prescribing 
practice.  
 
We must remember as prescribers that a drug has to be: 
 Available in a suitable form 
 Administered by an appropriate route 
 Absorbed into the body fluids and tissues 
 Distributed to its active site 
 Metabolised, primarily by the liver 
 Excreted, primarily by the kidneys 
These actions that occur after administration are pharmacokinetics and we shall begin by 
exploring the differences in this population of patient. 
 
Pharmacokinetics is the action of the body on the drugs that we take. It can be broken down 
into four processes as can be seen from table 1. (More detail on each of these processes is 
found in the article on pharmacokinetics in Volume 15, issue3). 
 
 Table 1- The four pharmacokinetic processes that occur after oral drug administration 
A- Absorption of the drug 
D- Distribution of the drug molecules 
M- Metabolism of the parent drug 
E- Excretion of the drug and its metabolites 
As with all areas of prescribing, it is wise to consider the seven principles of good prescribing 
practice when dealing with all patients 
Prescribing Pyramid (NPC 1999)
 
When considering prescribing in this particular subset of patients, it is important to remember 
additional information may need to be gathered and the way that you gather and use this 
information may be different. We will go on to explore the relevant areas of this framework.  
 
Exercise 
Using the BNF, look up the section on prescribing in the elderly. Review all the areas it 
discusses and reflect on how these may correlate with your area of prescribing. 
 
  
Consider the Patient 
 
Consideration of the patient should be modified to reflect the additional considerations 
required in the elderly. Normal manifestations of ageing need to be considered in context and 
not confused with symptoms or signs of disease. The main factors to consider in addition to 
normal consultation and examination are; 
 
• Changes to the normal pharmacokinetic processes 
• Altered sensitivity of some target organs 
• Increase incidence of multiple pathologies 
• Increased incidence of use of drugs with narrow therapeutic index 
• Potential increased risk of poor compliance 
• Potential increased chance of polypharmacy    
 
 
Changes to Pharmacokinetics 
 
Absorption 
Absorption of drugs from all administration routes except intravenous is required to get the drug from 
the site of administration to the blood stream. There are some specific considerations when 
prescribing in the elderly.  
There can be some issues in using the oral route of administration. Due to the normal manifestations 
of ageing there can be age related changes in the gut lumen that can compromise drug absorption. 
This is most commonly as a result of loss of surface area, thereby decreasing the absorbing site, 
reduced blood flow to this absorbing site and also changes to gastric acidity.  
It can also be that the food and fluid intake of an elderly person can be variable. They may eat smaller 
meals more often or can skip meals. This affects dosing for drugs that should be given with food or on 
an empty stomach and dosing regimens may need to be considered. Some patients may have 
swallowing problems and this may mean that either liquid preparations should be considered or if 
severe problems encountered, then another route of administration may be required. 
 
Distribution 
Distribution of drugs from the plasma to cell and tissues can be compromised. Plasma proteins play a 
crucial role in drug distribution and bioavailability and they can be reduced in number in elderly 
patients. Serum albumin can be measured if this is a potential area of concern. Circulatory issues can 
lead to reduced tissue perfusion so particular attention should be paid to drug disposition in these 
patients. Another factor is the change in body composition. There is a reduction in muscle and tissue 
mass and changes to the body fat and water ratio. These factors all combine to alter drug distribution 
and uptake into cells and tissues.  
Metabolism 
Drug metabolism primarily occurs in the liver. After the age of 65, liver size is reduced over time. The 
liver naturally has a large reserve so the loss of liver volume is not significant but there may be some 
corresponding reduction in liver function and this should be checked by blood test prior to heavily 
hepatically metabolised drugs. Reduction in drug metabolising enzymes also occurs and this needs to 
be taken into account especially when co prescribing drugs known to be hepatic enzyme inhibitors or 
inducers. There is also a reduction in liver blood flow which contributes to effective liver function.  
 
Excretion 
Drug excretion is largely carried out by the kidney for expulsion in urine. Reduced renal size and 
function in the older person results in decrease in renal perfusion which can result in a reduction in 
eGFR which can be measured and categorised. Other drugs can have an effect on renal function and 
care should be taken when co prescribing with drugs that are known to do this, especially NSAIDs 
Pharmacokinetic considerations relate to the ‘which strategy’ and ‘choice of product’ areas of the 
prescribing pyramid. 
Exercise 
Using the BNF, or other drug resource, look up a drug you are likely to prescribe in practice. 
Identify if there are any restrictions on prescribing in the elderly or in renal or hepatic 
impairment. Reflect on any changes you would need to make to dose or prescribing regimes 
in light of this.  
 
Other Areas to be Aware of 
 
Sensitivity to Medicines- pharmacodynamics 
As you will have discovered from your reading of the BNF section on prescribing in the 
elderly, they can be sensitive to some medicines. The main categories of drug that this is a 
concern with are listed below.  
 Opioids 
 Benzodiazepines 
 Antipsychotics 
 Antiparkinsonian drugs 
 NSAIDs 
 Antihypertensive agents 
 
These sensitivities are often pharmacodynamic and the elderly person can have a desired 
effect at a lower dose than is typical for an adult undergoing treatment, but increased risk of 
side effects and adverse effects at what is considered a normal adult therapeutic dose. This is 
especially true of the drugs with effects on the central nervous system, such as the opioids, 
benzodiazepines, antipsychotics and antiparkinsonian drugs listed above. Patients should be 
monitored for cognitive effects as well as sedation and started on lower doses and titrated up 
until effect is optimal. The antihypertensive can produce dramatic reductions in blood 
pressure in this group of patients increasing risk of falls. The action of the prescriber when 
managing elderly patients on these medications also falls under the ‘review’ section of the 
prescribing pyramid.  
 
Exercise 
Choose a drug group from those listed above that relates to an area of prescribing for you. 
Use the online medicines compendium or BNF online to look at the implications of 
prescribing this group in the elderly in more detail. Reflect ion how this may change your 
prescribing practice with regard to information gathering.  
 
Pathology/Comorbidity/ Polypharmacy 
There are many factors that contribute to the increase in medications taken by the over 65 
aged population. We have considered the pharmacokinetic and pharmacodynamic above in 
relation to ageing, but other factors also need to be considered before prescribing. If we look 
at this population and compare them with the general population, on average they will have a 
higher rate of chronic long term conditions, more than one condition at a time and be 
receiving care from more than one health care professional at a time.  This puts them at a 
higher risk of side effects and adverse reaction.  
Implications of disease needs careful consideration before prescribing. How many conditions 
are diagnosed, how many require medication and how many are actively being prescribed 
for?  As a prescriber, in your 'consideration of the patient’ you should be asking these 
questions and gathering information from the patient and any patient notes and recording 
your findings accurately (this fits with the record keeping aspect of the pyramid). This is 
often called ‘medicines reconciliation’ where you are the prescriber reconcile each 
medication with its related condition and ensure any prescribing in place is appropriate and 
safe before making any changes to the medication regime. The following key factors should 
be elucidated; 
• How many medicines? 
• Which conditions are they for? 
• Are they all needed? 
• What are the interactions risks? 
• Can you safely add in more medications if this was the aim of the patient contact? 
 
Polypharmacy has often been defined as ‘taking four or more medications concurrently’.  It is 
important to remember that polypharmacy in itself need not be harmful. Usually there are 
clear clinical indications for each prescribed drug, however, with an increased number of 
drugs we must as prescribers be aware of the risks that a high medication burden may bring.  
Interactions because of medication use increases as the number of drugs increases. Drug- 
drug interactions should be assessed for risk using Appendix one of the BNF before any 
additional drugs are prescribed. Polypharmacy must be considered at the same time as 
multimorbidity as looking at the medication burden alone, without considering the 
relationship of each drug to the condition it has been prescribed for, can be harmful in itself.  
 
Exercise 
Use appendix one of the BNF to investigate the incidence and severity of drug-drug 
interactions for medications you will often be prescribing together.  
 
Compliance 
Compliance with or adherence to medication regimes is not restricted to the elderly, but due to some 
of the other factors we have discussed above it can be more problematic for them due to other 
conditions, polypharmacy or any memory impairment. We should still always try to reach a 
concordant agreement and this falls under the ‘Negotiate a Contract’ section of the prescribing 
pyramid.  There can be many reasons why elderly patients do not take their medications as prescribed 
but these can be grouped into two categories of non-compliance; 
• Direct 
• Indirect 
Direct non-compliance refers to a patient who has made a conscious decision regarding the 
taking of their medication/s. Indirect usually refers to the patient still taking the medication 
but perhaps not when they should or how they should. This can lead to therapeutic plasma 
levels not being maintained and potential in-effect of a drug or toxic effect.  
Some patients may benefit from compliance aids or medication being put into special 
dispensing boxes to help them remember to take their medication at the right time and in the 
correct doses.  
 
Exercise 
Can you identify factors for the patients in your area of practice that might affect their ability to 
comply with or adhere to the medication regimes? Reflect on how you could manage these from a 
pharmacological perspective.  
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